Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Obesity on Effective Dose of Ciprofol for Loss of Consciousness
ChiCTR2400088616Phase 4Not yet recruiting
- Sponsor
- Baoding No. 1 Central Hospital
- Start
- Aug 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in Not applicable (3 arms), sponsored by Baoding No. 1 Central Hospital. Primary endpoints: Half-effective dose (ED50) of ciprofol for loss of consciousness, Pulse oxygen saturation (SpO2) and 1 more. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
Not applicable
Beyond the preview
Go deeper on ChiCTR2400088616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088616.